COVID-19 mortality among selective serotonin reuptake inhibitor users—results from a nationwide cohort

OBJECTIVE: To examine differences in mortality and/or severe acute respiratory syndrome between selective serotonin reuptake inhibitor- (SSRI) users and non-SSRI users up to 60 days after a positive SARS-CoV-2 real-time reverse transcription PCR test. METHODS: Retrospective cohort study including al...

Descripción completa

Detalles Bibliográficos
Autores principales: Stauning, Marius Ahm, Gür, Dogukan Jesper, Torp-Pedersen, Christian, Tingleff, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162844/
https://www.ncbi.nlm.nih.gov/pubmed/37150357
http://dx.doi.org/10.1016/j.cmi.2023.04.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162844/
https://www.ncbi.nlm.nih.gov/pubmed/37150357
http://dx.doi.org/10.1016/j.cmi.2023.04.028

Ejemplares similares